These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 12892687

  • 1. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H, Al-Azzawi F, UK VR Multicentre Trial Group.
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [Abstract] [Full Text] [Related]

  • 2. Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms.
    Al-Azzawi F, Buckler HM, United Kingdom Vaginal Ring Investigator Group.
    Climacteric; 2003 Jun; 6(2):118-27. PubMed ID: 12841882
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D, Posea C, Ceausu I, Rusu M.
    Eur Rev Med Pharmacol Sci; 2003 Jun; 7(5):117-25. PubMed ID: 15214586
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS, Kang BM, Yoon BK, Choi H, Park HM, Kim JG.
    Maturitas; 2007 Aug 20; 57(4):361-9. PubMed ID: 17467203
    [Abstract] [Full Text] [Related]

  • 5. A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women.
    Benster B, Carey A, Wadsworth F, Vashisht A, Domoney C, Studd J.
    Menopause Int; 2009 Jun 20; 15(2):63-9. PubMed ID: 19465671
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms.
    Speroff L, Haney AF, Gilbert RD, Ellman H, Estradiol Acetate Investigator Group.
    Menopause; 2006 Jun 20; 13(3):442-50. PubMed ID: 16735941
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
    Mattsson LA, Skouby S, Rees M, Heikkinen J, Kudela M, Stadnicki-Kolendo A, Mattila L, Salminen K, Vuorela A, Mustonen M, Indivina 321 Study Group.
    Menopause Int; 2007 Sep 20; 13(3):124-31. PubMed ID: 17785038
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May 20; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 9. Intranasal versus transdermal matrix oestrogen replacement in Australasian women.
    Davis SR, Davison SL, Wilson S, Shepherd J, Lawton B.
    Maturitas; 2005 Jun 16; 51(2):163-71. PubMed ID: 15917157
    [Abstract] [Full Text] [Related]

  • 10. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
    Cieraad D, Conradt C, Jesinger D, Bakowski M.
    Arch Gynecol Obstet; 2006 May 16; 274(2):74-80. PubMed ID: 16491367
    [Abstract] [Full Text] [Related]

  • 11. Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms.
    Utian WH, Speroff L, Ellman H, Dart C.
    Menopause; 2005 May 16; 12(6):708-15. PubMed ID: 16278614
    [Abstract] [Full Text] [Related]

  • 12. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 May 16; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 13. [Continuous, low dosage estradiol administration with a vaginal ring: a placebo-controlled study].
    Casper F, Petri E, Benninghoff B.
    Zentralbl Gynakol; 1998 May 16; 120(9):449-53. PubMed ID: 9796090
    [Abstract] [Full Text] [Related]

  • 14. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
    Rovati LC, Schmid K, Giacovelli G, Bonn M, Setnikar I, Wolff F, Genazzani AR.
    Arzneimittelforschung; 1999 Nov 16; 49(11):933-43. PubMed ID: 10604047
    [Abstract] [Full Text] [Related]

  • 15. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct 16; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 16. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
    Landgren MB, Helmond FA, Engelen S.
    Maturitas; 2005 Mar 14; 50(3):222-30. PubMed ID: 15734603
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C.
    Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463
    [Abstract] [Full Text] [Related]

  • 18. Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women.
    Nedstrand E, Wijma K, Wyon Y, Hammar M.
    Maturitas; 2005 Jun 16; 51(2):154-62. PubMed ID: 15917156
    [Abstract] [Full Text] [Related]

  • 19. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
    Chandeying V, Sangthawan M.
    J Med Assoc Thai; 2007 Sep 16; 90(9):1720-6. PubMed ID: 17957910
    [Abstract] [Full Text] [Related]

  • 20. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
    Ben-Chetrit A, Hochner-Celnikier D, Lindenberg T, Zacut D, Shimonovitz S, Gelber H, Spitz IM.
    Isr Med Assoc J; 2005 May 16; 7(5):302-6. PubMed ID: 15909462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.